El Hospital Virgen de las Nieves es una infraestructura sanitaria gestionada por el Servicio Andaluz de Salud, ubicada en la ciudad española de Granada. Es uno de los seis hospitales regionales de la comunidad, es decir, uno de los hospitales de mayor rango dentro del Sistema Sanitario Público de Andalucía.

During the past decade, Hospital Universitario Virgen de las Nieves conducted 176 clinical trials. In the 10-year time frame, 176 clinical trials started and 38 clinical trials were completed, i.e. on average, 21.6% percent of trials that started reached the finish line to date. In the past 5 years, 90 clinical trials started and 29 clinical trials were completed. i.e. 32.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Virgen de las Nieves" #1 sponsor was "PETHEMA Foundation" with 12 trials, followed by "Fundación Pública Andaluza Progreso y Salud" with 11 trials sponsored, "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 9 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored and "Spanish Breast Cancer Research Group" with 8 trials sponsored. Other sponsors include 230 different institutions and companies that sponsored additional 146 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen de las Nieves" #1 collaborator was "Sanofi" with 6 trials as a collaborator, "Abbott Medical Devices" with 5 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Iniciativa Andaluza en Terapias Avanzadas" with 5 trials as a collaborator and "Pfizer" with 5 trials as a collaborator. Other collaborators include 254 different institutions and companies that were collaborators in the rest 170 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen de las Nieves" are "Heart Failure" (10 trials), "Multiple Myeloma" (9 trials), "Acute Myocardial Infarction" (5 trials), "Atrial Fibrillation" (5 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Hospital Universitario Virgen de las Nieves" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Virgen de las Nieves" are "Drug" (159 trials), "Device" (38 trials), "Other" (36 trials), "Biological" (15 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Dexamethasone" (8 trials), "Lenalidomide" (6 trials), "Carboplatin" (4 trials) and "Cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Virgen de las Nieves" are 248 trials for "All" genders, 23 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Virgen de las Nieves". 4 are not yet recruiting, 58 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 142 completed trials in Hospital Universitario Virgen de las Nieves, 2 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Virgen de las Nieves, 11 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 38 trials, and there were also 22 trials that are defined as “Not Applicable".

Hospital Universitario Virgen de las Nieves has several departments that took part in Clinical trials: "Hospital Universitario Virgen de las Nieves; Servicio de Oncologia" - 6 trials, "Hospital Universitario Virgen de las Nieves; Servicio de Hematologia" - 3 trials, "Hospital Virgen de las Nieves; Servicio de Neumologia" - 2 trials